Provides genetic immunosequencing tests used to diagnose and treat diseases.
Industry: Health Care
First Day Return: +101.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/30/2019 |
Offer Price | $20.00 |
Price Range $18.00 - $19.00 | |
Offer Shares (mm) | 15.0 |
Deal Size ($mm) | $300 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/26/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $300 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Seattle, WA, United States |
Founded | 2009 |
Employees at IPO | 346 |
Website www.adaptivebiotech.com |